The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients
Abstract
Background Between 1986 and 1998, eight cases of community-acquired pneumonia due to Staphylococcus aureus strains carrying the gene for the Panton-Valentine leukocidin (PVL) were recorded in France, six of which were fatal. We aimed to assess the clinical features of these eight cases, and those of other cases identified prospectively, and to compare them with the characteristics of patients with pneumonia caused by PVL-negative strains.Methods We compared eight retrospective and eight prospective cases of PVL-positive S aureus pneumonia with 36 cases of PVL-negative S aureus pneumonia. For all patients, we recorded age, length of hospital stay, risk factors for infection, signs and symptoms, laboratory findings, antibiotic treatment, and serial radiological findings.Findings Median age was 14.8 years (IQR 5.4-24.0) for the PVL-positive patients and 70.1 years (59.2-81.4) for the others (p=0.001). Influenza-like illness had occurred during the 2 days before admission in 12 of the 16 PVL-positive patients, but in only three of 33 PVL-negative patients (p<0.001). PVL-positive infections were more often marked by: temperature greater than 39 degrees C (p=0.01), heart rate above 140 beats per min (p=0.02), haemoptysis (p=0.005), onset of pleural effusion during hospital stay (p=0.004), and leucopenia (p=0.001). The survival rate 48 h after admission was 63% for the PVL-positive patients and 94% for PVL-negative individuals (p=0.007). Histopathological examination of lungs at necropsy from three cases of necrotising pneumonia associated with PVL-positive S aureus showed extensive necrotic ulcerations of the tracheal and bronchial mucosa and massive haemorrhagic necrosis of interalveolar septa.Interpretation PVL-producing S aureus strains cause rapidly progressive, haemorrhagic, necrotising pneumonia, mainly in otherwise healthy children and young adults. The pneumonia is often preceded by influenza-like symptoms and has a high lethality rate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the recently emerged USA300 and USA400 clones that have been linked to a surge in necrotizing pneumonia in patients with influenza [9-11, 15, 29-31] act synergistically with influenza virus.”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [30]
In the citing paper
“which has been proposed as a marker for the enhanced virulence of USA300 and USA400 clones, particularly when their ability to cause necrotizing pneumonia in humans has been considered [30,31].”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [30]
In the citing paper
“Influenza-staphylococcal coinfections have increased following the emergence of the USA300 and USA400 lineages [9,11,30,31], and S. aureus has been identified as a common cause of death during the recent H1N1 influenza pandemic [12,15].”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [30]
Citations
Cites
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Self-citationNosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, N. N. I. S. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501795 · Cited by 1,028
Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction
Murakami, K., Minamide, W., Wada, K., Nakamura, E., Teraoka, H., & Watanabe, S. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.10.2240-2244.1991 · Cited by 951
The staphylococci in human disease
Crossley, K., & Archer, G. L. (1996) · Churchill Livingstone eBooks · Cited by 625
Prévost, G., Cribier, B. J., Couppié, P., Petiau, P., Supersac, G., Finck‐Barbançon, V., Monteil, H., & Piémont, Y. (1995) · Infection and Immunity · doi:10.1128/iai.63.10.4121-4129.1995 · Cited by 299
Self-citationEpidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins
Prevost, G., Couppie, P., Prevost, P., Gayet, S., Petiau, P., Cribier, B., Monteil, H., & Piemont, Y. (1995) · Journal of Medical Microbiology · doi:10.1099/00222615-42-4-237 · Cited by 269
Self-citationSchwarzmann, S. W. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.1971.00310180053006 · Cited by 238
Plotkowski, M.-C., Puchelle, E., Beck, G., Jacquot, J., & Hannoun, C. (1986) · American Review of Respiratory Disease · doi:10.1164/arrd.1986.134.5.1040 · Cited by 231
Kaneko, J., Kimura, T., Narita, S., Tomita, N., & Kamio, Y. (1998) · Gene · doi:10.1016/s0378-1119(98)00278-9 · Cited by 231
Cited by
Sorted by citations
Items 401–500 of 1,000
Futagawa‐Saito, K., Sugiyama, T., Karube, S., Sakurai, N., Ba‐Thein, W., & Fukuyasu, T. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5324-5326.2004 · Cited by 57
Antibiotic resistance in Staphylococcus aureus and its relevance in therapy
Bal, A. M., & Gould, I. M. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.13.2257 · Cited by 58
Eguia, J. M., & Chambers, H. F. “. (2003) · Current Infectious Disease Reports · doi:10.1007/s11908-003-0087-6 · Cited by 57
Molecular characterization ofStaphylococcus aureusin Lebanon
Tokajian, S. T., Khalil, P. A., JABBOUR, D., Rizk, M. A., Farah, M., Hashwa, F., & Araj, G. F. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810000440 · Cited by 56
Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia
Strålin, K. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.06.037 · Cited by 56
Nanotheranostics: A Possible Solution for Drug-Resistant Staphylococcus aureus and their Biofilms?
Mosselhy, D. A., Assad, M. A., Sironen, T. A., & Elbahri, M. (2021) · Nanomaterials · doi:10.3390/nano11010082 · Cited by 56
Panton–Valentine leukocidin is expressed at toxic levels in human skin abscesses
Badiou, C., Dumitrescu, O., Croze, M., Gillet, Y., Dohin, B., Hayi-Slayman, D., Allaouchiche, B., Étienne, J., Vandenesch, F., & Lina, G. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02105.x · Cited by 55
Self-citationZakour, N. L. B., Guinane, C. M., & Fitzgerald, J. R. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01384.x · Cited by 55
Syrmis, M. W., Moser, R. J., Whiley, D. M., Vaska, V. L., Coombs, G. W., Nissen, M. D., Sloots, T. P., & Nimmo, G. R. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03521.x · Cited by 55
Masiuk, H., Kopron, K., Grumann, D., Goerke, C., Kolata, J., Jursa-Kulesza, J., Giedrys‐Kalemba, S., Bröker, B. M., & Holtfreter, S. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02094-09 · Cited by 56
Influenza in Children and Adolescents: Epidemiology, Management, and Prevention
Wolf, R. M., & Antoon, J. W. (2023) · Pediatrics in Review · doi:10.1542/pir.2023-005962 · Cited by 54
Ma, X., Chang, W., Zhang, C., Zhou, X., & Yu, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034970 · Cited by 54
Hayward, A. C., Knott, F. A., Petersen, I., Livermore, D. M., Duckworth, G. J., Islam, A., & Johnson, A. M. (2008) · Emerging infectious diseases · doi:10.3201/eid1505.070153 · Cited by 54
Galia, L., Ligozzi, M., Bertoncelli, A., & Mazzariol, A. (2019) · AIMS Microbiology · doi:10.3934/microbiol.2019.2.138 · Cited by 54
Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus
Pacheco, G. A., Gálvez, N. M. S., Soto, J. A., Andrade, C. A., & Kalergis, A. M. (2021) · Microorganisms · doi:10.3390/microorganisms9061293 · Cited by 54
Community acquired bacterial pneumonia
Anevlavis, S., & Bouros, D. E. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903508770 · Cited by 54
Staphylococcus aureus Arsenal To Conquer the Lower Respiratory Tract
Pivard, M., Moreau, K., & Vandenesch, F. (2021) · mSphere · doi:10.1128/msphere.00059-21 · Cited by 61
Self-citationXie, X., Bao, Y., Ouyang, N., Dai, X., Pan, K., Chen, B., Deng, Y., Wu, X., Xu, F., Li, H., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1684-y · Cited by 53
Prevalence and Characterization of PVL-Positive Staphylococcus aureus Isolated from Raw Cow’s Milk
Sadat, A., Shata, R. R., Farag, A. M. M., Ramadan, H. H., Alkhedaide, A. Q., Soliman, M. M., Elbadawy, M., Abugomaa, A., & Awad, A. (2022) · Toxins · doi:10.3390/toxins14020097 · Cited by 53
Staphylococcus aureus bacteraemia in Gauteng academic hospitals, South Africa
Smidt, M. F.-D., Singh-Moodley, A., Badat, R., Quan, V., Kularatne, R. S., Nana, T., Lekalakala, R., Govender, N. P., & Perovic, O. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.10.011 · Cited by 52
Karaüzüm, H., Adhikari, R. P., Sarwar, J., Devi, V. S., Abaandou, L., Haudenschild, C. C., Mahmoudieh, M., Boroun, A. R., Vu, H., Nguyen, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065384 · Cited by 52
Tadros, M., Williams, V. L., Coleman, B. L., McGeer, A., Haider, S., Lee, C., Iacovides, H., Rubinstein, E., John, M., Johnston, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075171 · Cited by 52
Alonzo, F., & Torres, V. J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003143 · Cited by 54
Yoong, P., & Pier, G. B. (2012) · Infection and Immunity · doi:10.1128/iai.06360-11 · Cited by 54
Shambat, S. M., Chen, P., Hoang, A. T. N., Bergsten, H., Vandenesch, F., Siemens, N., Lina, G., Monk, I. R., Foster, T. J., Arakere, G., et al. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.021923 · Cited by 54
Self-citationJiang, L., Yi, T., Shen, Z., Teng, Z., & Wang, J. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00157 · Cited by 52
The emergence of severe, community-acquired methicillin-resistant Staphylococcus aureus infections
Crum, N. F. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540510033636 · Cited by 52
Lo, W., Lin, W.-J., Tseng, M., Lu, J., Lee, S.-Y., Chu, M., & Wang, C. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-51 · Cited by 52
Oral Antibiotic Therapy of Serious Systemic Infections
Cunha, B. A. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.07.009 · Cited by 51
Moussa, I. M., & Shibl, A. M. (2009) · Saudi Medical Journal · doi:10.15537/1658-3175.4711 · Cited by 51
Humanized Mouse Models of Staphylococcus aureus Infection
Parker, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00512 · Cited by 52
Staphylococcus aureus , Antibiotic Resistance, and the Interaction with Human Neutrophils
Rungelrath, V., & DeLeo, F. R. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8127 · Cited by 55
Serious Complications from Staphylococcal aureus in Atopic Dermatitis
Patel, D., & Jahnke, M. (2015) · Pediatric Dermatology · doi:10.1111/pde.12665 · Cited by 50
Nickerson, E. K., Wuthiekanun, V., Wongsuvan, G., Limmathurosakul, D., Srisamang, P., Mahavanakul, W., Thaipadungpanit, J., Shah, K. R., Arayawichanont, A., Amornchai, P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006512 · Cited by 50
Ellis, M. W., Griffith, M. E., Jorgensen, J. H., Hospenthal, D. R., Mende, K., & PATTERSON, J. E. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02352-08 · Cited by 50
Community-Associated Meticillin-Resistant Staphylococcus aureus Infections
Patel, M. (2009) · Drugs · doi:10.2165/00003495-200969060-00004 · Cited by 50
Barton, M., Hawkes, M., MOORE, D. L., Conly, J. M., Nicolle, L. E., Allen, U., Boyd, N., Embreé, J., Horne, L. V., Saux, N. L., et al. (2006) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2006/402361 · Cited by 50
Thuong, T. C., Tho, N. D., Hoa, N. T., Phương, N. T. M., Tuấn, L. V., Diep, T. S., Lindsay, J. A., Dung, N. T., Cam, B. V., Thinh, L. Q., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000822 · Cited by 53
Martin, C. A., Hoven, A. D., & Cook, A. M. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0489-3 · Cited by 50
Song, Y. J., Du, X., Li, T., Zhu, Y., & Li, M. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.050971-0 · Cited by 50
Methicillin-resistantStaphylococcus aureusin Taiwan
Chen, F.-J., Lauderdale, T.-L. Y., Huang, I., Lo, H., Lai, J., Wang, H.-Y., Shiau, Y., Chen, P., Ito, T., & Hiramatsu, K. (2005) · Emerging infectious diseases · doi:10.3201/eid1111.050367 · Cited by 49
Ho, P., Cheng, V. C., & Chu, C. (2009) · CHEST Journal · doi:10.1378/chest.09-0285 · Cited by 50
von Dach, E., Diene, S. M., Fankhauser, C., Schrenzel, J., Harbarth, S., & François, P. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv489 · Cited by 49
Chheng, K., Tarquinio, S., Wuthiekanun, V., Sin, L., Thaipadungpanit, J., Amornchai, P., Chanpheaktra, N., Tumapa, S., Putchhat, H., Day, N., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006630 · Cited by 48
Looking toward basic science for potential drug discovery targets against community‐associated MRSA
Otto, M. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20160 · Cited by 48
Kraushaar, B., & Fetsch, A. (2014) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2014.06.018 · Cited by 48
Vourli, S., Vagiakou, H., Ganteris, G., Orfanidou, M., Polemis, M., Vatopoulos, A. C., & Malamou-Ladas, H. (2009) · Eurosurveillance · doi:10.2807/ese.14.02.19089-en · Cited by 48
Olsen, R. J., Kobayashi, S. D., Ayeras, A. A., Ashraf, M., Graves, S. F., Ragasa, W., Humbird, T. L., Greaver, J. L., Cantu, C., Swain, J. L., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090960 · Cited by 48
Jin, T., Bokarewa, M. I., McIntyre, L. M., Tarkowski, A., Corey, G. R., Reller, L. B., & Fowler, V. G. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05145-0 · Cited by 48
Welte, T., Kantecki, M., Stone, G. G., & Hammond, J. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.08.012 · Cited by 48
Rumpf, C., Lange, J., Bianca, S., & Kahl, B. C. (2021) · Pathogens · doi:10.3390/pathogens10091177 · Cited by 48
Robert, J., Étienne, J., & Bertrand, X. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01173.x · Cited by 48
Ellington, M. J., Hope, R., Ganner, M., Ganner, M., East, C., Brick, G., & Kearns, A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm206 · Cited by 48
Staphylococcal Infections: A Historical Perspective
Shinefield, H. R., & Ruff, N. L. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2008.10.007 · Cited by 48
Community-Associated Methicillin-Resistant Staphylococcus aureus and Its Emerging Virulence
Shukla, S. K. (2005) · Clinical Medicine & Research · doi:10.3121/cmr.3.2.57 · Cited by 48
Population genetics and the evolution of virulence in Staphylococcus aureus
Chua, K., Howden, B. P., Jiang, J., Stinear, T. P., & Peleg, A. Y. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.04.026 · Cited by 50
Crandon, J. L., Banevicius, M. A., & Nicolau, D. P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00647-08 · Cited by 47
Joo, E., Chung, D. R., Ha, Y. E., Park, S. Y., Kang, S., Kim, S. H., Kang, C., Peck, K. R., Lee, N. Y., Ko, K. S., et al. (2012) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.04.018 · Cited by 47
Lo, W., & Wang, C. (2011) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2011.02.008 · Cited by 49
Rahimi, F., Katouli, M., & Karimi, S. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.06.031 · Cited by 47
[Guidelines for the treatment on infections caused by methicillin-resistant Staphylococcus aureus].
Mensa, J., Barberán, J., Llinares, P., Picazo, J. J., Bouza, E., Álvarez-Lerma, F., Borges, M. D. S., Serrano, R., León, C., Guirao, X., et al. (2008) · PubMed · Cited by 47
Shadyab, A., & Crum‐Cianflone, N. F. (2012) · HIV Medicine · doi:10.1111/j.1468-1293.2011.00978.x · Cited by 46
Staphylococcus aureus resistentes à meticilina: disseminação emergente na comunidade
Gelatti, L. C., Bonamigo, R. R., Becker, A. P., & d’Azevedo, P. A. (2009) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962009000500009 · Cited by 47
Laventie, B., Rademaker, H. J., Saleh, M., de Boer, E., Janssens, R., Bourcier, T., Subilia, A., Marcellin, L., van Haperen, R., Lebbink, J. H. G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102265108 · Cited by 46
Rouha, H., Weber, S., Janesch, P., Maierhofer, B., Gross, K., Doležílková, I., Mirkina, I. I., Visram, Z., Malafa, S., Stulik, L., et al. (2017) · Virulence · doi:10.1080/21505594.2017.1391447 · Cited by 47
Pérez-Montarelo, D., Viedma, E., Larrosa, N., Gómez-González, C., de Gopegui, E. R., Gallego, I. M., Juan, R. S., Fernández‐Hidalgo, N., Almirante, B., & Cháves, F. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02210 · Cited by 46
Severe infections of Panton-Valentine leukocidin positive Staphylococcus aureus in children
Hoppe, P.-A., Holzhauer, S., Lala, B., Bührer, C., Gratopp, A., Hanitsch, L. G., Humme, D., Kieslich, M., Kallinich, T., Lau, S., et al. (2019) · Medicine · doi:10.1097/md.0000000000017185 · Cited by 46
Prognostic factors of severe community-acquired staphylococcal pneumonia in France
Gillet, Y., Tristan, A., Rasigade, J., Saadatian‐Elahi, M., Bouchiat, C., Bes, M., Dumitrescu, O., Leloire, M., Dupieux, C., Laurent, F. J., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04445-2020 · Cited by 49
Self-citationBacterial Community-Acquired Pneumonia in Older Patients
Donowitz, G. R., & Cox, H. L. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.03.006 · Cited by 46
Résistance aux antibiotiques chezStaphylococcus aureus
Dumitrescu, O., Dauwalder, O., Boisset, S., Reverdy, M. E., Tristan, A., & Vandenesch, F. (2010) · médecine/sciences · doi:10.1051/medsci/20102611943 · Cited by 46
Self-citationWu, K., Conly, J. M., McClure-Warnier, J.-A., Elsayed, S., Louie, T., & Zhang, K. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02765.x · Cited by 46
Community-Associated Methicillin-Resistant Staphylococcus aureus: New Bug, Old Drugs
Sabol, K., Echevarria, K. L., & Lewis, J. S. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g404 · Cited by 46
Poultsides, L. A., Papatheodorou, L. K., Karachalios, T. S., Khaldi, L., Maniatis, A. N., Petinaki, E., & Malizos, Κ. Ν. (2008) · Journal of Orthopaedic Research® · doi:10.1002/jor.20608 · Cited by 45
Studying Staphylococcal Leukocidins: A Challenging Endeavor
Tromp, A. T., & van Strijp, J. A. G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00611 · Cited by 45
Molecular diagnostics in medical microbiology: yesterday, today and tomorrow
vanBelkum, A. F. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00108-5 · Cited by 45
Strategies for managing today's infections
Carmeli, Y. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01957.x · Cited by 47
Staphylococcus aureus exfoliative toxins: How they cause disease.
Plano, L. R. W. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.1523-1747.2004.22144.x · Cited by 45
Lung, T. W. F., Chan, L. C., Prince, A. S., Yeaman, M. R., Archer, N. K., Aman, M. J., & Proctor, R. A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1060810 · Cited by 46
Figueiredo, A. M. S., & Ferreira, F. A. (2014) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276140016 · Cited by 44
The pathogenicity and host adaptation of livestock-associated MRSA CC398
Ballhausen, B., Kriegeskorte, A., van Alen, S., Jung, P., Köck, R., Peters, G., Bischoff, M., & Becker, K. (2016) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.05.006 · Cited by 44
Effects of Coal Fly Ash Particulate Matter on the Antimicrobial Activity of Airway Surface Liquid
Buonfiglio, L. G. V., Mudunkotuwa, I. A., Alaiwa, M. H. A., Calderón, O. G. V., Borcherding, J. A., Gerke, A. K., Zabner, J., Grassian, V. H., & Comellas, A. P. (2017) · Environmental Health Perspectives · doi:10.1289/ehp876 · Cited by 44
Characterisation of methicillin-resistant Staphylococcus aureus isolates from dogs and their owners
Boost, M. V., O'Donoghue, M. M., & Siu, G. G. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01737.x · Cited by 44
Quorum-sensing systems in staphylococci as therapeutic targets
Harraghy, N., Kerdudou, S., & Herrmann, M. (2006) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-006-0860-0 · Cited by 44
Klein, J., Petrovic, Z., Treacher, D., & Edgeworth, J. D. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1844-6 · Cited by 44
Welsh, K. J., Abbott, A. N., Lewis, E. M., Gardiner, J. M., Kruzel, M. C., Lewis, C. T., Mohr, J., Wanger, A. R., & Armitige, L. Y. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01949-09 · Cited by 44
Microbes and the fate of neutrophils
Kobayashi, S. D., DeLeo, F. R., & Quinn, M. T. (2022) · Immunological Reviews · doi:10.1111/imr.13163 · Cited by 45
Sharma‐Kuinkel, B. K., Ahn, S. H., Rude, T. H., Zhang, Y., Tong, S. Y. C., Ruffin, F., Genter, F. C., Braughton, K. R., DeLeo, F. R., Barriere, S. L., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.06219-11 · Cited by 43
Monecke, S., Müller, E., Buechler, J. A., Rejman, J. J., Stieber, B., Akpaka, P. E., Bandt, D., Burris, R., Coombs, G. W., Hidalgo-Arroyo, G. A., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02285-12 · Cited by 43
Chou, D.-W., Wu, S., Chung, K.-M., Han, S.-C., & Cheung, B. M.-H. (2016) · Clinics · doi:10.6061/clinics/2016(10)02 · Cited by 43
Carrera, M., Böhme, K., Gallardo, J. M., Barros‐Velázquez, J., Cañas, B., & Calo‐Mata, P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02458 · Cited by 43
Niemann, S., Bertling, A., Brodde, M. F., Fender, A. C., de Vyver, H. V., Hussain, M., Holzinger, D., Reinhardt, D., Peters, G., Heilmann, C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20582-z · Cited by 47
Prévost, G., Couppié, P., & Monteil, H. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200304000-00002 · Cited by 43
Bettin, A., Garcés, C. C., & Reyes, N. (2012) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2012.06.017 · Cited by 42
Staphylococcal Bicomponent Pore-Forming Toxins: Targets for Prophylaxis and Immunotherapy
Aman, M. J., & Adhikari, R. P. (2014) · Toxins · doi:10.3390/toxins6030950 · Cited by 42
Graves, S. F., Kobayashi, S. D., Braughton, K. R., Diep, B. A., Chambers, H. F. “., Otto, M. J., & DeLeo, F. R. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.02.005 · Cited by 43
Genetic nature and virulence of community-associated methicillin-resistant Staphylococcus aureus
Yamamoto, T., Hung, W., Takano, T., & Nishiyama, A. (2013) · Biomedicine · doi:10.1016/j.biomed.2012.12.001 · Cited by 42
Lees, N., Rosenberg, A., Hurtado-Doce, A., Jones, J., Marczin, N., Zeriouh, M., Weymann, A., Sabashnikov, A., Simon, A., & Popov, A. (2016) · Journal of Artificial Organs · doi:10.1007/s10047-016-0915-8 · Cited by 42
Motoshima, M., Yanagihara, K., Morinaga, Y., Matsuda, J., Sugahara, K., Yamada, Y., Kohno, S., & Kamihira, S. (2010) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.220.165 · Cited by 42
Different Types of Cell Death Induced by Enterotoxins
Lin, C., Chen, C., Huang, W., Cheng, Y., Hsieh, C.-Y., Wang, C., & Hong, M. (2010) · Toxins · doi:10.3390/toxins2082158 · Cited by 42
Deurenberg, R. H., Vink, C., Driessen, C., Bes, M., London, N. H. H. J., Étienne, J., & Stobberingh, E. E. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.09.031 · Cited by 42
Self-citation
Metadata
- Authors
- Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., & Etienne, J.
- Affiliations
- Hôpital Edouard Herriot (FR)
- Inserm (FR)
- Hôpital Necker-Enfants Malades (FR)
- Université de Strasbourg (FR)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 359
- Issue
- 9308
- Pages
- 753-759
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2133530652
- Cited by
- 1,514
- References
- 38
- Citations by year
- 2026: 23 · 2025: 26 · 2024: 24 · 2023: 38 · 2022: 36 · 2021: 31 · 2020: 46 · 2019: 47 · 2018: 38 · 2017: 50 · 2016: 61 · 2015: 52 · 2014: 76 · 2013: 72 · 2012: 84
- FWCI
- 37.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Minnesota Department of Health
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- Staphylococcus aureus, Panton-Valentine leukocidin, necrotizing pneumonia, community-acquired pneumonia, children, influenza-like illness, hemorrhagic necrosis, pleural effusion, hemoptysis, leukopenia, mortality, virulence factors, clinical features
- MeSH terms
- Adolescent, Adult, Bacterial Toxins, Bronchi, Child, Child, Preschool, Exotoxins, Female, France, Humans, Leukocidins, Male, Necrosis, Pneumonia, Staphylococcal, Prospective Studies, Pulmonary Alveoli, Staphylococcus aureus, Trachea, Virulence, Community-Acquired Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review